IPOPEMA Securities (WAR:IPE) Other Current Liabilities: zł22.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:IPE IPOPEMA Securities SA WAR:IPE
57 GF Score
Price zł7.30
GF Value zł3.62
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is IPOPEMA Securities Other Current Liabilities?

IPOPEMA Securities WAR:IPE -1.35% 57 Other Current Liabilities is zł22.1 Mil as of Mar. 2026. GuruFocus rates WAR:IPE with a GF Score™ of 57/100 and a GF Value™ of zł3.62 (Significantly Overvalued). The stock has 8 warning signs investors should review.

IPOPEMA Securities's other current liabilities for the quarter that ended in Mar. 2026 was zł22.1 Mil.

IPOPEMA Securities's quarterly other current liabilities declined from Sep. 2025 (zł15.9 Mil) to Dec. 2025 (zł5.8 Mil) but then increased from Dec. 2025 (zł5.8 Mil) to Mar. 2026 (zł22.1 Mil).

IPOPEMA Securities's annual other current liabilities declined from Dec. 2023 (zł32.5 Mil) to Dec. 2024 (zł3.4 Mil) but then increased from Dec. 2024 (zł3.4 Mil) to Dec. 2025 (zł5.8 Mil).

IPOPEMA Securities Other Current Liabilities Related Terms

IPOPEMA Securities Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for IPOPEMA Securities's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IPOPEMA Securities Other Current Liabilities Chart

IPOPEMA Securities Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.99 15.81 32.52 3.45 5.82

IPOPEMA Securities Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.14 15.58 15.86 5.82 22.14
WAR:IPE
57GF Score
IPOPEMA Securities SA WAR:IPE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IPOPEMA Securities Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of zł22.1 Mil mean?
IPOPEMA Securities (WAR:IPE) has a Other Current Liabilities of zł22.1 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on IPOPEMA Securities.
Is IPOPEMA Securities' Other Current Liabilities too high?
IPOPEMA Securities' current Other Current Liabilities is zł22.1 Mil. Overall, IPOPEMA Securities has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' Other Current Liabilities compare to MS and GS?
IPOPEMA Securities' Other Current Liabilities of zł22.1 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Capital Markets company?
A good Other Current Liabilities depends on the Capital Markets industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on IPOPEMA Securities. IPOPEMA Securities's current Other Current Liabilities is zł22.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.62, compared to a current price of zł7.30 — trading 101.7% above its estimated fair value. The current Other Current Liabilities is zł22.1 Mil. IPOPEMA Securities' overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current Other Current Liabilities is zł22.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?

Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued. The current stock price of zł7.30 is trading 101.7% above its estimated GF Value™ of zł3.62. GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.

Key valuation signals for WAR:IPE:

  • Other Current Liabilities: zł22.1 Mil
  • GF Value™: zł3.62 vs. price of zł7.30 (101.7% above fair value)
  • GF Score™: 57/100 with 8 warning signs

No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IPOPEMA Securities Business Description

Address 9 Prozna Street, Warsaw, POL, 00-107
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
57GF Score

Get the complete analysis for WAR:IPE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł7.30
Price
zł3.62
GF Value